# Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial

Article · Ania M. Jastreboff, Donna H. Ryan, Harold Edward Bays, Peter Robert Ebeling, Mia Mackowski, Nisha Philipose, Leorah H. Ross, Yimeng Liu, Cassandra E Burns, Siddique A. Abbasi, Nicola Pannacciulli

- Archive id: doi:10.1056/nejmoa2504214
- Published: 2025-06-23
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2504214
- PMID: 40549887
- Citations: 110
- Source URL: https://doi.org/10.1056/nejmoa2504214
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.